The presence of robotic devices in rehabilitation centers is now becoming commonplace across the world, challenging heath care professionals to rethink treatment strategies for motor impairment in hemiparetic stroke patients. In this article, we will discuss some of the motivations for using these devices, review clinical outcomes following robotic-assisted training in both the upper and lower extremities, and detail how these devices can provide quantitative evaluations of function. We will also address the clinical issues that need to be considered when using robotic devices to treat stroke patients, and finally a vision of where this field is heading will be discussed.
O ver the last decade, the integration of robotic devices into neurorehabilitation centers across the world has reshaped clinical strategies when considering treatment options for individuals with motor impairments resulting from neurological injuries. What began as proof-of-concept testing in the 1990s has evolved into widespread acceptance among many researchers and clinicians. Today, robotic devices are being used as rehabilitative tools for treating physical impairments in both the upper and lower limbs. Because these devices have precise instrumentation that measures variables such as position and forces, they are also being used to diagnose and assess motor impairments such as spasticity, tone, and strength with great accuracy. Because they are driven with mechanical motors, these devices can automate repetitive tasks such as passive ranging, active reaching, and gait training in time-unlimited durations. Furthermore, in instances where more than one therapist is necessary to provide a therapeutic intervention, such as gait training a severely impaired acute stroke patient, robotic devices may also help reduce health care costs. It must be emphasized that the goal of introducing rehabilitation robots into clinics is not to replace physical and occupational therapists, but rather robots are a complement to existing treatment options.
Although there are numerous potential benefits to adopting these technologies into the rehabilitation setting, there are also some potential drawbacks, including safety, clinician and patient acceptance, and the ability to bill for time on these devices. Because rehabilitation robots come with state-of-the-art technology, the up-front costs can be overwhelming for smaller centers.
In this review article, we will discuss some of the key findings and contemporary issues surrounding the introduction of robotic devices into neurorehabilitation programs targeting hemiparetic stroke patients. First, the motivation and potential benefits of using rehabilitation robotics will be discussed. Then, clinical outcomes following robotic training programs will be presented and interpreted for both the upper and lower extremities. Next, we will discuss how these devices can be used as diagnostic tools that provide quantitative evaluations of function. A discussion of the clinical considerations that need to be taken into account when using robotic devices to treat stroke patients will be outlined, and finally a vision of where this field is heading will be proposed.
Motivation
The idea of massed-practice therapy is not a new concept in the world of rehabilitation professionals; it is used in various forms throughout occupational and physical therapy. One obvious limitation with this type of intervention from a health care cost perspective is that it is often quite labor intensive, requiring one-on-one therapist-patient interactions for highly impaired individuals. For example, manual-assisted gait training often requires multiple therapists, and even then it places excessive physical demands on the therapists that sometimes result in repetitive strain injuries, lower back problems, and extreme fatigue. It would be difficult if not impossible for even the most proficient and skilled therapist to maintain high-quality therapy across a full case load of patients who require this type of attention.
One of the main motivations for developing rehabilitation devices is to automate or assist interventions that normally require multiple therapists or that are extremely physically demanding. For example, during reach-to-grasp tasks, the robot can provide visual cues to the patient and then assist the movement if they are unable to complete the task. 1 As the patient regains function, the robot can make the task more challenging by adding resistance during the movements or perhaps adding obstacles the patient must navigate through or avoid. Because the movements are guided by an actuated device, the number of reaches is not limited in time or duration.
Another potential benefit of integrating these devices into rehabilitation clinics is that rehabilitation robots are able to accurately measure and track the patient's impairments over the course of a therapeutic intervention. Clinical scales such as FIM TM , 2* Ashworth, 3 and others are subjective and often suffer from poor interrater reliability. 4 Robotic devices can monitor or measure numerous behaviors within a session and across sessions, making it possible for the therapist to track improvements and also justify their time to health care providers and payers.
There is little doubt that our population is aging; it is projected that the size of the elderly population (those 65 years or older) will rise from approximately 33+ million (12.7% of US population in 1999) to 53 million in 2020 and 77 million by 2040. 5 From a health care cost perspective, this trend is troubling because, after the age of 55, the probability of suffering a stroke doubles with each decade, 6 and more than half of all stroke survivors are left with some long-term disability. 6 In parallel, economic pressures are forcing rehabilitation centers to treat patients in shorter periods of time. Often patients are discharged while they are continuing to make functional gains. Because the duration of inpatient stays at rehabilitation hospitals is decreasing and the number of outpatient therapy sessions is being continuously reduced, it is imperative to optimize the therapy patients are able to receive in the limited time window available to our clinicians and therapists.
Robot Therapy Clinical Outcomes
Since the concept of using robotic devices to deliver goal-directed physical therapy was first explored through a number of small controlled studies in the mid 1990s, 7, 8 dozens of trials have been conducted in both the upper and lower limbs. Here, we present summaries of both upper and lower limb studies that have looked at the effectiveness of robotic rehabilitation in facilitating the restoration of function in hemiparetic stroke survivors (see also refs. 9, 10, and 11 for reviews).
*FIM
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Upper limb robotic rehabilitation
Although there have been numerous devices designed to deliver arm therapy in individuals with neurological injuries, we highlight three that have undergone extensive testing with hemiparetic stroke subjects: MIT-MANUS, 8, 12, 13 ARM-GUIDE, 14 and MIME.
15,16
MIT-MANUS
The MIT-MANUS was developed at the Massachusetts Institute of Technology in the early 1990s 12 with the goal of determining whether repetitive reaching exercises using a robotic device can enhance recovery of the arm function in hemiparetic stroke survivors. The MANUS, as shown in Figure 1 , allows subjects to execute reaching movements in the horizontal plane. During movements, the device can assist or resist the subject and monitor arm position and applied forces. The manner in which the MANUS interacts with the subject is intended to be safe, stable, and compliant throughout the training paradigm.
A collection of cumulative studies utilizing the MIT-MANUS have been published for acute 8, 13, [17] [18] [19] hemiparetic stroke subjects with the goal of determining whether subjects who receive robotic-assisted arm therapy coincident with their conventional therapy make greater improvements in upper limb function than those who receive "sham" robot therapy along with their conventional therapy. In each of these studies, the robot-trained subjects used the MANUS to reach toward various targets across their workspace; if they were unable to complete the movement, the robot assisted them. On average, three packets of 20 repetitions were done with the impaired limb, totaling 4-5 hours per week over a 7-week period. The sham group received 1 hour of additional therapy per week, where they used the device for 30 minutes with their unimpaired arm and the other 30 minutes with their impaired arm. The motors on the MANUS were not turned on so that if these subjects did not complete their intended movement, they used their unaffected limb to assist the affected limb complete the task.
Evaluation of upper limb motor impairment and ability to carry out functional tasks was done before and after the intervention and included the FIM 2 ; subset of the upper limb Fugl-Meyer (FM) functional impairment scale 20 ; strength in the biceps, triceps, anterior, and posterior deltoid muscles using the Medical Research Council Motor Power (MP) scale; and Motor Status Score (MSS) for the shoulder-elbow complex (MSS-SE) and wrist-hand complex (MSS-WH). 21 After testing 96 acute stroke subjects (average of 2 weeks post stroke at enrollment) at the Burke Rehabilitation Hospital (White Plains, NY) through a double-blinded study, it was found that the robottrained group demonstrated significantly greater gains in elbow and shoulder motor function (MSS-SE, p < .001) and elbow and shoulder strength (MP, p < .005) than the sham control group. No significant differences were between groups were observed in Fugl-Meyer scores at the shoulder, elbow, wrist, or hand nor were there differences in FIM or motor function (MSS-WH) at the wrist and hand. A 3-year follow-up study evaluating 12 of the first 20 subjects enrolled in the study found that there were no significant differences in any of the outcome measures described earlier except for shoulder-elbow motor status score (MSS-SE, p < .05).
Recent studies have explored the idea of using the MIT-MANUS in chronic subjects 22, 23 and have found similar trends. That is, even in the chronic stages of their injury, subjects are able to improve shoulder and elbow function after training for 6 weeks with the robot. Furthermore, these gains were sustainable for at least 4 months, which suggests that long-term improvements in function are achievable even in the chronic stages of stroke.
Even though these studies demonstrate functional improvements in both acute and chronic stroke subjects following training on the MIT-MANUS arm robot, a few points of contention need to be raised. First, in the acute studies presented here, the control group only received 1 hour of extra therapy per week while the robottrained group received approximately 5 hours. Of this 1 hour of therapy, 30 minutes were spent training the unimpaired arm. So it is questionable whether true comparisons should be drawn between the two types of interventions. Furthermore, Volpe et al. 18 noted that the control group had significantly lower FIM motor and cognitive scores, and, while not statistically significant, there was a trend for the lesion volumes to be larger in the control group than in the robot-trained group. Each of these issues may raise questions about whether robot therapy with the MIT-MANUS is more effective than conventional therapy, but there is little doubt that the robot-trained group demonstrated statistically significant gains in function after repeated sessions with the device.
ARM-GUIDE
One possible limitation with the MIT-MANUS is that it emphasizes training within the horizontal plane. Subjects who trained on the MANUS did demonstrate improvements in shoulder strength and function, but some researchers have hypothesized that training in a three-dimensional workspace may enhance these functional gains. Reinkensmeyer et al.
14,24,25 developed a trombonelike device called the Assisted Rehabilitation and Measurement Guide (ARM-GUIDE) that allows stroke subjects to reach along a rail, which in turn can be positioned so that the subjects' reaching motion can be neutral to gravity or can work against gravity (Figure 2 ). Like the MIT-MANUS, the device is actuated with a motor that can assist or resist the subject's motion and is also instrumented to monitor hand position and speed. A 6-degree of freedom force sensor is mounted just below the handle so that forces exerted by the subject along the rail and also orthogonal to the desired motion can be quantified. The device can be adjusted in the elevation and yaw axes, and the extent of the movement can also be controlled. The device continues to be used as both a diagnostic tool (see the section, "Robot Therapy Clinical Outcomes") and a treatment tool for addressing arm impairment in hemiparetic stroke subjects.
A small controlled study was carried out that compared long-term arm training on the ARM-GUIDE to a control group that executed freereaching movements. 26 In this study, a group of chronic stroke subjects (more than 1-year post stroke) were trained; six subjects used the ARM-GUIDE and four acted as controls. The ARM-GUIDE group reached toward targets arranged across their reaching workspace with their impaired arm. In this setting, the ARM-GUIDE was pointed toward the selected target; after receiving a visual cue, the subject was instructed to try and reach toward the target as fast as possible. If the hand velocity of the subject followed a predetermined hand trajectory, then the motor on the ARM-GUIDE provided no assistance. However, if the subject reached either too fast or too slow, the device resisted or assisted the movement, respectively. In this setting, the subjects' goal was to follow a prescribed velocity path that spanned their range of motion. Graphical feedback of their hand position was provided during each reach.
The control group executed free reaching toward targets arranged on a wall that were similar in direction as the targets used in the ARM-GUIDE group. Here, the subjects were not constrained to move along any path; they were simply asked to reach toward the various targets at a comfortable speed. Each trial began with the hand of their impaired arm resting on their lap. A Flock of Birds (Ascension Technology Corporation, Milton, VT) sensor was placed on the back of the subjects' hand to monitor their reach trajectory. Visual feedback was also provided to this group after they completed a sequence of reaches.
Both groups were trained 3 days per week for 8 weeks, totaling 24 sessions. Evaluations of performance were done prior to and following training using the Chedoke-McMaster Upper Extremity Stroke Assessment Scale 27 for monitoring arm function and the Rancho Los Amigos Test 28 for evaluating each subject's ability to carryout everyday tasks. Subjects also carried out passive and active tests on the ARM-GUIDE to measure passive limb mechanics and voluntary reach range and speed.
It was found that both subject groups improved in the Chedoke-McMaster and Rancho Los Amigos Tests; however, there were no statistical differences between the improvements across groups. Furthermore, both groups demonstrated statistically significant improvements in active range of reach and reaching speed and demonstrated decreased passive resistance to movement (p < .05). However again, there were no statistical differences between groups, which indicated that both therapeutic interventions had similar effects.
While this study only consisted of 10 chronic stroke subjects, it raises questions about whether it is the mode of therapy or the amount of therapy that is ultimately important in restoring arm function to hemiparetic stroke subjects. It should be noted that the starting impairment level in the ARM-GUIDE group was slightly greater than that of the control subjects, which may slightly skew the results. However, it appears from this study that the results can be interpreted in at least two ways: robotic-assisted therapy is no more effective than conventional therapy, or the type of robotic- assisted therapy used in this study is not optimal for addressing arm impairment in this patient population. This group is currently exploring a variation of the ARM-GUIDE protocol to try and address this issue.
29
MIME
The final upper limb training protocol based on robotic-assisted movements that will be discussed was designed through a collaborative effort between the Veteran Administration Medical Center in Palo Alto and Stanford University and is called MIME (Mirror-Image Movement Enabler). 1, 15 The robot utilized in this protocol, a PUMA 560 industrial device (Staubli Corporation, Duncan, SC), was modified so that it could interact with subjects in a stable and repeatable manner. The subject's impaired limb was placed in a splint, which in turn was connected to the robot through a 6-degree of freedom force-torque sensor (Figure 3) . This sensor is able to measure the interaction forces between the subject and the device during reaching tasks. The device is fully instrumented so that the position of the subject's limb can be inferred through the robot's position. The idea behind this protocol was to explore the effectiveness of restoring arm function in stroke subjects by having them execute movements that mirror one another in both of their upper limbs.
In these studies, four different modes of operation were explored. In the first mode, the subject's arm was passively moved by the robot from a starting position to a target along some predetermined kinematic trajectory. During these movements, the subject was asked to relax the paretic limb and allow the device to passively move the arm. In the second mode of therapy, the subject would attempt to move to a target while the robot would stabilize the limb. The subject was only allowed to move in the direction of the target and not back toward the starting position. If the subject attempted to move toward the target and could not make it, the robot would support the limb and assist the movement. In the third mode of operation, the robot was programmed to provide some viscous resistance as the subject reached for the targets across the workspace. Finally, the fourth mode of training was developed to be bimanual in nature, where the subject would reach for symmetric targets using both arms at the same time, one connected to the robot and the other connected to a position-sensing digitizer. Here, the motion of the unimpaired forearm dictated the range and rate of the movements of the impaired arm that was assisted by the robot. The idea was that in the bimanual mode the subject had full control over the path and rate of movements of both arms.
To evaluate the effects of these robot modes of therapy in comparison to NeuroDevelopmental Therapy (NDT), 27 chronic stroke subject (more than 6 months post stroke) were tested, where each subject received 24 one-hour sessions over a 2-month period. 11 For the robot group, subjects practiced shoulder and elbow movements that were assisted by the robot. Here, targets were placed away from the subject so that the emphasis was placed on reaching movements to various points in the workspace. All subjects spent approximately 12 minutes in bimanual mode, 5 minutes in passive mode, and the remainder of the session in practicing active-assisted or active-resisted modes depending on their functional level. For the control group, subjects were trained using NDT; the subjects practiced various tasks with their arm that focused on functional or self-care tasks.
Evaluations of intervention effects were done at months 0, 1, and 2 and at a 6-month follow-up session and included Fugl-Meyer testing, 20 Barthel Index, 30 FIM, 2 and maximum strength testing under isometric conditions. Evaluation of active reach was also examined by having the subject make reaches to targets positioned at various places in a three-dimensional space, during which arm position and orientation were quantified using a lightweight, instrumented forearm splint.
Following 24 sessions of training, it was found that the subjects who received MIME therapy made statistically higher gains in proximal arm function (Fugl-Meyer scores), strength (elbow extension, shoulder flexion, and shoulder abduction and adduction), and the amount of active reach. The robot group made statistically faster gains in proximal arm function during the 2 months of training; however, at the 6-month follow-up, there were no statistical differences in function between the two groups. No changes were found between subjects in distal arm function or ability to perform activities of daily living (ADLs; Barthel Index or FIM).
In a similar study that only focused on subjects trained using the MIME protocol, 16 it was found that the amount of work the subjects were able to perform during active reaches had significantly increased. In subjects with low levels of function, the extent of reach had improved; in high-functioning subjects, the movement velocity was significantly higher. Improvements in elbow and shoulder muscle activation patterns were also observed in subjects who performed reaches against gravity, but no improvements were noted during table-top movements.
Preliminary summary: arm devices
This study, like the MIT-MANUS study, provides evidence that training with a robotic device can improve arm function in hemiparetic stroke subjects, but it is task specific. That is, both of these studies found that proximal arm function improved more rapidly and to a greater extent in the robot group, however distal arm function did not experience these same gains. Both devices used in these studies emphasize proximal tasks, so it is not surprising that changes in wrist and hand function were no different from those in the control groups.
What is somewhat disappointing in these studies is that subjects experienced improvements in function according to scales such as Fugl-Meyer and Motor Status Score, but changes in the subjects' ability to perform ADLs were no greater in the robot-trained group than they were in the control groups. One has to consider which aspect of recovery is more important to the consumer; the ability to perform things at home that would make them more independent or tests that are supposed to be indicative of their ability to perform ADLs. We postulate that future studies using these and other robotic devices must demonstrate clear benefits to the subjects' ability to perform ADLs, otherwise acceptance of these devices by the clinical community and the consumer will be significantly compromised.
Lower limb robotic rehabilitation
The concept of body weight-supported locomotor training is now being used extensively in most neurorehabilitation centers and is demonstrating promising results. Over the last 10 years, it has been shown that subjects who receive body weight-supported treadmill training after spinal cord injury [31] [32] [33] and stroke [34] [35] [36] demonstrate improved EMG activation patterns, 31,37 more natural walking characteristics, 35 are able to bear more weight on their legs, 32 and demonstrate functional improvement in walking ability. 33, 37 Furthermore, there are also reports of reductions in spasticity 33 and increases in cardiopulmonary efficiency 38 after body weight-supported locomotor training.
The major drawback of manual-assisted locomotor training is that it places large physical demands on the therapists, which limits the consistency and duration of training sessions. Furthermore, from a health care cost basis, manual-assisted locomotor training is quite expensive, as it often requires multiple therapists to properly administer. To address these limitations, a number of robotic gait trainers have been developed, all having the goal of delivering time-unlimited, consistent gait training in individuals with neurological injuries. We highlight two such devices that are currently being used in various clinics around the world: the Lokomat 39 and the Gait Trainer. 40 
Lokomat gait orthosis
The Lokomat robotic gait orthosis has been in development since the mid 1990s in order to automate the delivery of locomotor training for individuals with neurological injuries. 39 This system is comprised of a treadmill, a body weight-support system, and two lightweight robotic arms that attach to the subject's legs (Figure 4) . The Lokomat is fully programmable, including control of knee and hip kinematic trajectories, the amount of assistance the system provides to the subject, and the speed at which the subject ambulates. This high-level dynamic control is achieved by small direct current (DC) motors and linear ball screw assemblies at the hip and knee joints that are tightly synchronized with the timing of the treadmill. Hip and knee angles are monitored through high-precision potentiometers while dorsiflexion is provided at the ankle of the subject through two passive elastic straps. Unloading of the patient is achieved by connecting the shoulder straps on a harness to a counterweight system. Furthermore, force sensors mounted in series with the motors sense the amount of resistance/assistance the subject is generating while walking in the device, which can be used as biofeedback for motivational purposes. The Lokomat is an FDA-approved medical device.
Because the Lokomat has only been commercially available since 2002 (Hocoma AG, Volketswil, Switzerland), no large-scale studies have been published comparing the effects of Lokomat gait training to conventional gait training in hemiparetic stroke subjects. A multicenter study currently being conducted by the National Rehabilitation Hospital and the Rehabilitation Institute of Chicago is investigating this question in subacute stroke subjects (less than 6 months post stroke), where it is anticipated that the results of more than 100 participants will be reported in the fall of 2007. That study is being sponsored by the National Institute on Disability and Rehabilitation Research (NIDRR) under Rehabilitation Engineering Research Center (RERC) "Machines Assisting Recovery from Stroke (MARS)."
Mechanized Gait Trainer
Another robotic device that targets gait training in stroke subjects is the Gait Trainer 40,41 developed in Germany, which works very similarly to traditional elliptical trainers. In this setting, the subject's feet are strapped to two footplates, which in turn are connected to a linkage system that moves the foot through a trajectory quasi-similar to the gait cycle. The foot is always connected to the platforms, and the positioning and loading of the foot on the Gait Trainer is comparable to the stance and swing phases of the gait cycle, with a ratio of 60% and 40% for each phase, respectively.
The stride length and phase durations can be adjusted by using different gear ratios on the linkage system, while the step velocity is modulated between 0 to 1.12 m/s. Furthermore, the linkages connected to the footplates are connected to a motor that can provide varying levels of assistance throughout the gait cycle, ranging from full support when the subject provides no assistance to little or no support when the subject actively propels his or her legs. Similar to the Lokomat, the forces generated by the subject can be used as biofeedback during training.
A randomized crossover design was performed to evaluate the effectiveness of using the mechanized Gait Trainer in a group of nonambulatory stroke subjects (n = 30; 4-12 weeks poststroke). 36 Subjects enrolled in the study were randomly assigned to one of two groups: a group that received treatments A-B-A and a group that received treatments B-A-B. Intervention A consisted of 15-20 minutes of daily locomotor training on the Gait Trainer for 2 weeks; intervention B consisted of the same doses of therapy only on the treadmill. In the robot and treadmill interventions, a portion of the subject's body weight was supported using an overhead unloading system. Furthermore, assistance with weight shifts and leg kinematics (e.g., foot placement and knee control) was provided by a therapist in both groups as required for each subject. Evaluations of walking ability consisted of the Functional Ambulation Category (FAC), 42 gait velocity, and Rivermead Motor Assessment Score, 43 and ankle spasticity was quantified using the modified Ashworth scale. 3 Assessments were performed by an independent evaluator blinded to the subject's treatment group before training, weekly, and finally at a 6-month follow-up visit.
After 6 weeks of therapy, both the A-B-A group and B-A-B group demonstrated improvements in walking ability (FAC), walking speed, and Rivermead scores. FAC scores were found to be statistically higher in the A-B-A group than the B-A-B group, however there were no group differences in walking speed or Rivermead scores. No changes in ankle spasticity were found in either group. By the 6-month follow-up evaluation, none of the outcome measures were statistically different across groups.
For the robot intervention, therapy sessions could be carried out by one therapist even in highly impaired subjects; whereas for the treadmill training intervention, sometimes three therapists were needed to properly train low-functioning subjects. This likely cost productivity highlights one of the benefits of robotic rehabilitation, particularly with the current health care economic pressures.
A potential limitation with the Gait Trainer is that the system does not directly control the knee or hip joints nor is the trunk supported. In acute stroke subjects, weakness across the knee and hip joints often results in poor joint stability, so that hyperextension may occur unless otherwise controlled by a therapist or trainer. Furthermore, because the subject's feet are always attached to the pedals, unnatural cutaneous inputs to the bottom of the feet may alter sensory inputs normally experienced during gait. Nevertheless, the outcomes of this study provide promising indications that robotic-assisted gait training may result in positive returns in walking ability.
Preliminary summary: gait training devices
Although there are limited experimental results supporting the effectiveness of robotic-assisted devices in restoring walking function in hemiparetic stroke subjects, the need for gait-specific devices is of high importance because training subjects with significant motor impairment is labor intensive and often requires multiple therapists. If devices such as the Lokomat or Gait Trainer can replicate results in neurological subjects that are similar to the results experienced after manual-assisted locomotor training, the cost benefits of robotic devices may ultimately help facilitate their adoption into rehabilitation centers.
Quantifying Impairment Using Robotic Devices
The section "Robot Therapy Clinical Outcomes" highlighted various studies of the effectiveness of robotic devices as therapeutic tools for upper and lower limb rehabilitation, but these devices are also well-suited to quantify motor function and impairments in hemiparetic stroke subjects. Because all of the devices discussed previously are fully instrumented with sensors that measure limb position, velocities, and forces, these variables can be used to study impairment with a high degree of precision. Furthermore, this information can also be used to track recovery and perhaps even dose therapy. By better understanding the mechanisms underlying impairment, more effective treatments may ultimately be developed. In this section, we discuss a few examples of robotic devices used to evaluate arm and leg function in hemiparetic stroke survivors.
Previously, we highlighted the MIT-MANUS (Figure 1) as a therapeutic tool for aiding in the recovery of arm function in stroke subjects. The MIT-MANUS has also been used to track changes in smoothness during arm movements 8, 44 and the ability to execute continuous arm movements. 45 Both of these characteristics, smoothness and continuity, are inherent characteristics of coordinated human movement. 46 In these studies, stroke subjects were instructed to either make point-to-point linear movements or draw a circle. The resulting hand movements were examined for the number of corrective movements made, the shape of the velocity profile, and other metrics of smoothness. It was found that throughout the course of recovery, stroke subjects demonstrate improvements in their ability to execute smooth, continuous movements that are similar to nonneurologically impaired subjects. For example, Krebs et al. 8 showed that prior to robot training, when subjects attempted to draw circles, the shape of the circle was highly distorted and a large number of corrective movements were made. However, through the progression of the intervention, the shape of each movement became more circular and the velocity profile began resembling a bell-shape with less corrective movements, both being normal characteristics.
Reinkensmeyer et al. 24, 25 utilized the ARM-GUIDE (Figure 2) to study active and passive restraints exhibited by chronic stroke subjects during guided reaching. Subjects were instructed to reach as far and as fast as possible along the guide and to try not to push up or down or left or right against the device. The arm was also moved through the entire range of motion by the device while the subject relaxed in order to evaluate passive tissue properties. It was found that during ac-tive reaches subjects generate large and significant forces against the rail perpendicular to the desired movement. These forces were consistent with the synergy patterns previously reported in chronic stroke subjects. 47, 48 Furthermore, it was found that passive tissue constraints were significantly higher in the impaired arm and that deficits in active reach extent were attributable to spasticity and weakness. These studies demonstrate the utility of robotic devices to investigate the mechanisms underlying arm dysfunction in stroke subjects.
Techniques are also being developed to evaluate walking ability and gait impairments using robotic devices. 49 The goal of this work is to establish the optimal set of training parameters, such as walking speed and level of body weight support, for maximizing the effectiveness of the therapy. A standard Lokomat (Figure 4 ) has been modified in two distinct ways. First, the cuffs that couple the subject's legs to the Lokomat have been customized to contain 6-degree of freedom load sensors that allow for the accurate measurement of the assistance or resistance the device provides the subject. Second, a split belt treadmill that resides under the Lokomat contains sensors that allow for the calculation of ground reaction forces and centers of pressure. Utilizing the leg-Lokomat interaction forces, the ground reaction forces, and the kinematic data (e.g., position and velocity of the legs), a modified inverse-dynamics technique is used to estimate the ankle, knee, and hip moments the subject generates under any set of training parameters. Combining this information with electromyographic (EMG) information, the role of impairments such as weakness, spasticity, and abnormal synergies on walking ability can be studied, and the set of training parameters through which the subject steps to generate the best joint moments and muscle activation patterns can be identified. The goal is to train subjects under conditions that may lead to higher returns in walking ability after long-term locomotor training.
Clinical Considerations When Incorporating Robotic Devices into Rehabilitation Centers
A major consideration of most facilities with regard to using robotics will be the cost effectiveness of treatment. The purchase of robotic systems such as the Lokomat or MIT-MANUS presents a significant expense for any clinical facility. There are numerous administrative costs related to clinical use of the robotic as well. Therapists and aides must be trained to use the equipment safely and effectively; this is nonreimbursable time for the department. Training not only involves learning how to properly set-up the patients into the device but also gaining a detailed understanding of both the hardware and software that accompany the robot. Once the proper fit has been determined, an aide might be able to perform any necessary set-up of the robot prior to the patient getting into the robotic system, but the therapist should check the set-up before any training begins.
Unlike most physical therapy settings where a therapist might see more than one patient at a time, robotic training currently requires one-onone treatment. While this may soon change for some devices (see the section, "Future Directions"), currently group therapy with these devices is not possible and therefore impacts department revenue. In some robotic devices, particularly the gait trainers, an additional person in the lab is often necessary for efficiency and safety purposes. For example, due to co-morbidities in the patient populations using the Lokomat (typically SCI, CVA, and TBI), blood pressure, cardiac, or diabetic issues can arise during training sessions. Although training can be accomplished safely with one person, it often requires a minimum of two people to get a patient safely out of the device when time is critical. With the proven benefit of robotics, the potential to increase referrals to therapy and the increased revenue generated from those referrals might offset some costs.
In addition to cost issues, there are numerous treatment considerations with robotic therapy. For such interventions to be used in the clinic, the benefit must be established through ongoing clinical research trials. Currently, a motor learning approach is the generally accepted method to retraining movement with neurologically impaired individuals. Motor learning theory has been incorporated into therapy practice since the 1990s when Carr and Shepard advocated its use with NDT. 50 Regardless of the treatment philosophy, in general the adopted strategy is a principle of active, high repetition, task-specific practice.
Before bringing a robot into the clinic as a training tool, a clinician might ask if the robot can provide these needed practice conditions. Therapists will also want to know that adequate and/or varied learning conditions can be provided with a robotic device.
Another hurdle to overcome before robotics become a standardized treatment tool may be acceptance from the clinicians themselves. Therapists pride themselves on their ability to use their hands for evaluation and treatment. Their hands are the "tools of the trade." Clinicians may feel that the robot eliminates this aspect of practice that they feel is implicit to their profession. Other clinicians may fear that new technology could replace them in the clinic. Yet, the ability to assess and plan for the patient's individual needs is still dependent on the therapist's expertise and judgment. Robotics are technologies that are developed to assist therapists in attaining optimal outcomes for patients. In treatment, a robot may replace the therapist's hands to assist with heavy, challenging, or repetitious movement and ease physical strain on the therapist. A robot could also be used as a tool to allow for massed or varied practice of a difficult movement task. The therapist's hands and eyes will continue to provide the information that is used to evaluate the patient's movement strategies. Data from the robot can quantify what clinicians may be seeing and feeling (see the section, "Quantifying Impairment Using Robotic Devices") and can provide them with objective information on current performance that can be compared to past and future performance.
Future Directions
Whereas the last decade has taken rehabilitation robotics from concept to reality, the upcoming years will test these devices with extreme rigor to determine whether they should be considered as daily treatment options across various patient populations. Furthermore, advances in technology will result in these machines becoming lighter and more powerful, perhaps opening up new opportunities and therapies. Before devices like those profiled in this article can be made more effective, we must first understand which interventions best promote recovery. Once a particular mode of intervention has been shown to be effective, it only makes sense to then wonder whether a robotic device can help deliver it more effectively. The design and construction of devices that are not based on evidence-based practice or on solid therapeutic principles shown to be effective will surely lead to failure.
Robotic devices must also overcome the cost hurdles discussed in the section "Clinical Considerations When Incorporating Robotic Devices into Rehabilitation Centers." Krebs et al. 13 proposed that the MIT-MANUS could be used in a classroom fashion, where one therapist could oversee multiple patients who were each using the device. Such practice is currently being performed in Austria with the Lokomat, where one technician simultaneously trains more than one subject at a time on two devices side by side. Ultimately, the safety of these devices must be shown to be such that the occurrence of patient injuries is no higher than what is seen routinely in clinics.
We must also evaluate patient satisfaction and therapist satisfaction with the clinical use of rehabilitation robots. Krebs et al. 8 surveyed their research subjects; even though all subjects felt that the robot training was productive and assisted their recovery, they all preferred the therapist to the robot. Even though clinical rehabilitation robots mostly work in tandem with therapists rather than autonomously, issues such as patient comfort, anxiety, and tolerance must be taken into account.
Finally, we propose that clinical acceptance in this field will come only after well-controlled studies are performed demonstrating the effectiveness of robotic devices. For each device, these studies will need to identify which patients are appropriate and will likely demonstrate improvements in function, training parameters, training dosages, and other determinants surrounding the therapeutic intervention. To date, we have relied on heuristic rules for establishing parameters and dosing the therapies, because there were little or no foundations from which to work. Now that there is a growing body of literature in the field of rehabilitation robotics, our next steps must be to design, build, and test devices based on evidence and not assumption.
